Antisense oligonucleotides with different backbones - Modification of splicing pathways and efficacy of uptake

被引:81
作者
Schmajuk, G
Sierakowska, H
Kole, R
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.274.31.21783
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel, positive read-out assay that quantifies only sequence-specific nuclear activity of antisense oligonucleotides was used to evaluate morpholino and 2'-O-methyl sugar-phosphate oligonucleotides. The assay is based on modification of the splicing pathway of human beta-globin pre-mRNA, In addition, scrape-loading of cells with oligonucleotides allows the separate assessment of intracellular antisense activity of the oligonucleotides and their ability to penetrate the cell membrane barrier. The results show that, with scrape-loading, the morpholino oligonucleotides were approximately 3-fold more effective in their intrinsic antisense activity than alternating phosphodiester/phosphorothioate 2'-O-methyl-oligoribonucleotides and 6-9- and almost 200-fold more effective than the exclusively phosphorothioate and phosphodiester derivatives, respectively. The morpholino oligonucleotides were over 20-fold more effective than the phosphorothioate 2'-O-methyl-oligoribonucleotides in free uptake from the culture media. The antisense activity of the morpholino oligonucleotides was detectable not only in monolayer HeLa cells but also in suspension K562 cells. Time course experiments suggest that both the free uptake and efflux of morpholino oligonucleotides are slow.
引用
收藏
页码:21783 / 21789
页数:7
相关论文
共 57 条
[1]  
Agrawal S, 1998, APPLIED ANTISENSE OLIGONUCLEOTIDE TECHNOLOGY, P365
[2]   Mac-1 (CDllb/CD18) is an oligodeoxynucleotide-binding protein [J].
Benimetskaya, L ;
Loike, JD ;
Khaled, Z ;
Loike, G ;
Silverstein, SC ;
Cao, L ;
Khoury, JE ;
Cai, TQ ;
Stein, CA .
NATURE MEDICINE, 1997, 3 (04) :414-420
[3]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[4]   EXON RECOGNITION IN VERTEBRATE SPLICING [J].
BERGET, SM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (06) :2411-2414
[5]   Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers [J].
Bielinska, A ;
KukowskaLatallo, JF ;
Johnson, J ;
Tomalia, DA ;
Baker, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (11) :2176-2182
[6]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301
[7]   Antisense drug discovery: Can cell-free screens speed the process? [J].
Branch, AD .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (03) :249-254
[8]   BETA-THALASSEMIA IN CHINESE - USE OF INVIVO RNA ANALYSIS AND OLIGONUCLEOTIDE HYBRIDIZATION IN SYSTEMATIC CHARACTERIZATION OF MOLECULAR DEFECTS [J].
CHENG, TC ;
ORKIN, SH ;
ANTONARAKIS, SE ;
POTTER, MJ ;
SEXTON, JP ;
MARKHAM, AF ;
GIARDINA, PJV ;
LI, A ;
KAZAZIAN, HH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (09) :2821-2825
[9]  
Cioffi CL, 1997, MOL PHARMACOL, V51, P383
[10]   Vitravene™ -: another piece in the mosaic [J].
Crooke, ST .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1998, 8 (04) :VII-VIII